Literature DB >> 17611218

Cardiotoxicity of trastuzumab in clinical practice.

Heather L McArthur, Stephen Chia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17611218     DOI： 10.1056/NEJMc070065

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  Management of breast cancer--Part II.

Authors:  Nicholas C Turner; Alison L Jones
Journal:  BMJ       Date:  2008-07-11

2.  Trastuzumab-related cardiotoxicity among older patients with breast cancer.

Authors:  Mariana Chavez-MacGregor; Ning Zhang; Thomas A Buchholz; Yufeng Zhang; Jiangong Niu; Linda Elting; Benjamin D Smith; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

Review 3.  High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.

Authors:  Genevieve Conant; Benjamin Fook Lun Lai; Rick Xing Ze Lu; Anastasia Korolj; Erika Yan Wang; Milica Radisic
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 4.  Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship.

Authors:  Graeme J Koelwyn; Michel Khouri; John R Mackey; Pamela S Douglas; Lee W Jones
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

5.  Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer.

Authors:  Mariana Chavez-MacGregor; Jiangong Niu; Ning Zhang; Linda S Elting; Benjamin D Smith; Jose Banchs; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

6.  Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study.

Authors:  Martina Bonifazi; Matteo Franchi; Marta Rossi; Lorenzo Moja; Alberto Zambelli; Antonella Zambon; Giovanni Corrao; Carlo La Vecchia; Carlo Zocchetti; Eva Negri
Journal:  Oncologist       Date:  2013-07-03

7.  Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.

Authors:  Xianglin L Du; Rui Xia; Keith Burau; Chih-Chin Liu
Journal:  Med Oncol       Date:  2010-10-22       Impact factor: 3.064

Review 8.  Role of trastuzumab in the management of HER2-positive metastatic breast cancer.

Authors:  Andrea Milani; Filippo Montemurro; Luisa Gioeni; Massimo Aglietta; Giorgio Valabrega
Journal:  Breast Cancer (Dove Med Press)       Date:  2010-11-24

Review 9.  Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.

Authors:  Michel G Khouri; Pamela S Douglas; John R Mackey; Miguel Martin; Jessica M Scott; Marielle Scherrer-Crosbie; Lee W Jones
Journal:  Circulation       Date:  2012-12-04       Impact factor: 29.690

Review 10.  Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics.

Authors:  Ming Hui Chen; Risto Kerkelä; Thomas Force
Journal:  Circulation       Date:  2008-07-01       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.